Get the latest Science News and Discoveries

Existing drugs studied in patients with rare immune diseases - EurekAlert


<p><strong>This month the first study within the DRIMID consortium (DRIMID stands for <em>Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases</em>) has started. This study will investigate the efficacy and safety of the drug filgotinib (approved for treatment of rheumatoid arthritis and ulcerative colitis) in three rare immune diseases (Beh&ccedil;et&#39;s disease, idiopathic inflammatory myositis, IgG4-related disease). DRIMID aims to investigate whether this drug - despite the absence of formal drug approval - can also be used to treat these rare immune diseases.</strong></p>

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of patients

patients

Photo of existing drugs

existing drugs

Photo of EurekAlert

EurekAlert

Related news:

News photo

Wake up and die: Human brain neurons re-entering the cell cycle age quickly shift to senescence - EurekAlert

News photo

2 USC faculty members named 2024 Guggenheim Fellows - EurekAlert

News photo

In the brain, bursts of beta rhythms implement cognitive control - EurekAlert